Netherlands· NL-c74ee0621787
Brivaracetam Amarox 25 mg filmomhulde tabletten
A brivaracetam product containing brivaracetam, registered in Netherlands by Amarox Pharma B.V.. The same ATC class is registered in 18 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Brivaracetam is registered in 18 of 19 countries.
Countries holding a registration under ATC N03AX23 (brivaracetam), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Brivaracetam · ATC N03AX23
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of brivaracetam costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $2.61 in France to $22.97 in Switzerland — a ×8.8 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Brivaracetam · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$22.97
- IT Italy$3.99
- FR France$2.61
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BRIVARACETAM
- Manufacturer
- Amarox Pharma B.V.
- Country
- Netherlands (NL)
- ATC code
- N03AX23
- ATC class
- Brivaracetam
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id133087
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
91 interactions on record for brivaracetam.
Graded by severity as the source publishes them — 63 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Brivaracetam · interactions on record
91 records
- 63 moderate
- 28 minor
Most severe, free to view
- MetoclopramideA03FA01moderate
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Brivaracetam in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaABAVALEXG.L. Pharma GmbH, Lannach
- SpainBRIVARACETAM CINFA 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGLaboratorios Cinfa S.A.
- FinlandBrabelaExeltis Healthcare S.L.
- United StatesbrivaracetamNovadoz Pharmaceuticals LLC
- SwedenAbavalex 25 mg Filmdragerad tablettG.L. Pharma GmbH
- PolandAbavalexG.L. Pharma GmbH
- ItalyBRIVARACETAM DOCDOC GENERICI S.R.L.
- IcelandBrivaracetam AdalvoAdalvo Competence Center SRL
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Abavalex, Brivaracetam Genericon
- Belgium · Brivaracetam Teva
- Bulgaria · Abavalex
- Cyprus · Brivaracetam Accord
- Czechia · Abavalex, Breluncol
- Germany · Abavalex, Brivaracetam 1 A Pharma
- Denmark · Abavalex, Brivaracetam Cipla
- Spain · Brivaracetam Cinfa, Brivaracetam Combix
- Finland · Brabela, Brivaracetam Desitin
- France · Brivaracetam Biogaran, Brivaracetam La Colina
- United Kingdom (Northern Ireland) · Brivaracetam Alissa, Brivaracetam Altair
- Greece · Brivaracetam Anabiosis, Brivaracetam Anfarm
- Croatia · Brivaracetam Accord, Brytyn
- Hungary · Abavalex, Breluncol
- Ireland · Brivaracetam Clonmel
- Iceland · Brivaracetam, Brivaracetam Stada
- Italy · Brileps, Brivaracetam Amarox
- Liechtenstein · Briviact
- Malta · Brivaracetam Anfarm, Brivaracetam Clonmel
- Norway · Brivaracetam Desitin, Brivaracetam Glenmark
- Poland · Abavalex, Brabela
- Portugal · Brabela, Brivaracetam Anfarm
- Romania · Abavalex, Breluncol
- Sweden · Abavalex, Brivaracetam Amarox
- Slovenia · Clizay
- Slovakia · Abavalex, Breluncol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a097aa13-da16-4b94-b51e-e166912f8cb1 GET /v1/drugs/a097aa13-da16-4b94-b51e-e166912f8cb1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h133087_smpc.pdf",
"strength": null,
"atc_label": "Brivaracetam",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg133087",
"excipients": [
"CROSCARMELLOSE NATRIUM (E 468)",
"IJZEROXIDE ROOD (E 172)",
"LACTOSE 0-WATER",
"LACTOSE 1-WATER",
"MACROGOL 3350",
"MAGNESIUMSTEARAAT (E 470b)",
"POLYVINYLALCOHOL (E 1203)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"BRIVARACETAM"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h133087.pdf",
"authorised_at": "2025/10/22",
"procedure_number": "DE/H/8015/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "133087",
"additional_monitoring": "N"
}See everything about brivaracetam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.